Subscribe to RSS
DOI: 10.1055/s-2007-990955
One-Pot Synthesis of Highly Functionalized Oxindoles under Swern Oxidation Conditions
Publication History
Publication Date:
19 October 2007 (online)
Abstract
The reaction of indole derivatives bearing a 3- or 4-hydroxyalkyl chain with dimethyl sulfoxide and oxalyl chloride under Swern conditions led to a one-pot process involving three different synthetic transformations, namely oxidation of indole to oxindole, introduction of a chlorine substituent at the oxindole C-3 position, and substitution of the hydroxyl group in the side chain by chlorine. In spite of its mechanistic complexity, this synthetically useful process proceeded in good to excellent overall yield.
Key words
indoles - Swern reaction - oxindole synthesis - halogenation - oxidation
- 1
Tokunaga T.Hume WE.Nagamine J.Kawamura T.Taiji M.Nagata R. Bioorg. Med. Chem. Lett. 2005, 15: 1789 -
2a
Smith CD.Zilfou JT.Stratmann K.Patterson GML.Moore RE. Mol. Pharmacol. 1995, 47: 241 -
2b
Zhang X.Smith CD. Mol. Pharmacol. 1996, 49: 288 - 3
Zaveri NT.Jiang F.Olsen CM.Deschamps JR.Parrish D.Polgar W.Toll L. J. Med. Chem. 2004, 47: 2973 - 4
Alcaraz M.Atkinson S.Cornwall P.Foster AC.Gill DM.Humphries LA.Keegan PS.Kemp R.Merifield E.Nixon RA.Noble AJ.O’Beirne D.Patel ZM.Perkins J.Rowa P.Sadler P.Singleton JT.Tornos J.Watts AJ.Woodland IA. Org. Process Res. Dev. 2005, 9: 555 - 5
Kikuchi C.Hiranuma T.Koyama M. Bioorg. Med. Chem. Lett. 2002, 12: 2549 - 6
Gallagher G.Lavanchi PG.Wilson JW.Hieble JP.DeMarinis RM. J. Med. Chem. 1985, 28: 1533 - For early surveys of oxindole alkaloids, see:
-
7a
Cordell GA. An Introduction to Alkaloids: A Biogenetic Approach Wiley-Interscience; New York: 1981. -
7b
Bindra JS. Oxindole Alkaloids, In The Alkaloids - Chemistry and Physiology Vol. 14:Manske RHF. Academic Press; New York: 1973. p.83 - 8
Abourriche A.Abboud Y.Maoufoud S.Mohou H.Seffaj T.Charrouf M.Chaib N.Benamara A.Bontemps N.Francisco C. Farmaco 2003, 58: 1351 -
9a Isolation:
Cui CB.Kakeya H.Okada G.Onose R.Osada H. J. Antibiot. 1996, 49: 527 -
9b Structure:
Cui C.Kakeya H.Osada H. Tetrahedron 1996, 52: 12651 - Total syntheses:
-
9c
Edmonson S.Danishefsky SJ. Angew. Chem. Int. Ed. 1998, 37: 1138 -
9d
Wang H.Ganesan A. J. Org. Chem. 2000, 65: 4685 -
9e
Sebahar PR.Williams RM. J. Am. Chem. Soc. 2000, 122: 5666 -
9f
Von Nussbaum F.Danishefsky SJ. Angew. Chem. Int. Ed. 2000, 39: 2175 -
9g Cytotoxic activity:
Edmondson SE.Danishefsky SJ.Sepp-Lorenzino L.Rosen N. J. Am. Chem. Soc. 1999, 121: 2147 - For reviews of the chemistry of the welwitindolinones, see:
-
10a
Avendaño C.Menéndez JC. Curr. Org. Synth. 2004, 1: 65 -
10b
Menéndez JC. In Bioactive Heterocycles V, In Topics in Heterocyclic Chemistry Vol. 11: Springer; Berlin/Heidelberg: 2007. p.63 -
11a
Szabo-Pusztay K.Szabo L. Synthesis 1979, 276 -
11b
Underwood R.Prasad K.Repic O.Hardtmann G. Synth. Commun. 1992, 22: 343 -
11c
Cushing TD.Sanz-Cervera JF.Williams RM. J. Am. Chem. Soc. 1993, 115: 9323 - 12 For a review of the synthesis of 2-oxindoles, see:
Karp GM. Org. Prep. Proced. Int. 1993, 25: 481 - 13
Bailey PD.Cochrane PJ.Irvine F.Morgan KM.Pearson DPJ.Veal KT. Tetrahedron Lett. 1999, 40: 4593 - 14 Some of these compounds are known in the literature. See:
Harrington PE.Kerr MA. Synlett 1996, 1047 - 15
Wuest FR.Kniess T. J. Labelled Compd. Radiopharm. 2005, 48: 31 - Compound 8a has been previously obtained in 7% yield by treatment of alcohol 6a with NCS in CH2Cl2 followed by addition of aq NH4Cl. See:
-
18a
Hino T.Miura H.Nakagawa T.Murata R.Nakagawa M. Heterocycles 1975, 3: 805 -
18b
Hino T.Miura H.Murata R.Nakagawa M. Chem. Pharm. Bull. 1978, 26: 3695 - A related spirocyclization was observed after exposure of two N-acyltryptophan derivatives to DMSO-Ms2O at-20 °C for 5 h, which gave the corresponding five-membered spirolactones in yields of around 65% as mixtures of diastereomers. See:
-
20a
Büchi G.DeShong PR.Katsumura S.Sagimura Y. J. Am. Chem. Soc. 1979, 101: 5084 - For a similar reaction using a mixture of DMSO and tert-butyl bromide, see:
-
20b
Palla G.Marchelli R.Casnati G.Dossena A. Gazz. Chim. Ital. 1982, 112: 535 -
20c
Labroo RB.Labroo VM.King MM.Cohen LA. J. Org. Chem. 1991, 56: 3637 - 22
Nozoye T.Shibanuma Y.Nakai T.Hatori H. Chem. Pharm. Bull. 1988, 36: 4980 - 23
McComas CC.Perales JB.Van Vranken DL. Org. Lett. 2002, 3: 2337
References and Notes
Representative Experimental Procedure
To a solution of oxalyl chloride (5 equiv) in anhyd CH2Cl2 (10 mL), at -78 °C under an argon atmophere, was added DMSO (7 equiv). The solution was stirred for ca. 10 min, until effervescence ceased. A solution of alcohol 6b (350 mg, 0.77 mmol) in anhyd CH2Cl2 (3 mL) was added dropwise via cannula, and the red solution was stirred for 10 min at -78 °C. Then, Et3N (10 equiv) was added and the solution was left to warm to r.t. for 20 min, while stirred. The reaction mixture was diluted with CH2Cl2 (20 mL) and washed with sat. aq NH4Cl (3 × 20 mL). The organic layer was dried (Na2SO4) and evaporated, and the residue was purified by rapid chromatography on silica gel, eluting with PE-EtOAc mixtures (gradient from 20:1 to 5:1), to yield compound 8b (357 mg, 90%). Slower chromatographic separation may lead to considerable amounts of decomposition products, specially from hydrolysis of the terminal chloromethylene moiety.
Data for Representative Compounds 8
Compound 8b: IR (film on NaCl): 1731.6 (C=O), 1112.9 (C-O) cm-1. 1H NMR (250 MHz, CDCl3): δ = 7.73-7.67 (m, 4 H, H-2′′,6′′), 7.50-7.35 (m, 8 H, H-5,6,3′′,4′′,5′′), 6.77 (d, 1 H, J = 7.6 Hz, H-7), 5.07 (d, 1 H, J = 14.2 Hz, CH2O), 4.90 (d, 1 H, J = 14.2 Hz, CH2O), 3.31-3.13 (m, 2 H, H-3′), 3.21 (s, 3 H, NCH3), 2.40-2.17 (m, 2 H, H-1′), 1.43-1.28 (m, 2 H, H-2′), 1.12 [s, 9 H, C(CH3)3]. 13C NMR (62.9 MHz, CDCl3): δ = 173.2 (C-2), 142.4 (C-7a), 139.1 (C-4), 135.5 (C-2′′,6′′), 133.0 (C-1′′), 130.5 (C-6), 129.9 (C-4′′), 127.8 (C-3′′,5′′), 123.2 (C-3a), 121.6 (C-5), 107.4 (C-7), 64.4 (C-3), 60.9 (CH2O), 43.6 (C-3′), 35.6 (C-1′), 27.7 (C-2′), 26.85 (NCH3), 26.75 [C(CH3)3], 19.3 [C(CH3)3]. Anal. Calcd for C29H33Cl2NO2Si: C, 66.15; H, 6.32; N, 2.66. Found: C, 65.97; H, 6.02; N, 2.36.
Compound 8d (major diastereomer, 8da; minor diastereomer, 8db): IR (film on NaCl): 1729.0 (C=O) cm-1. 1H NMR (250 MHz, CDCl3): δ = 7.35-7.25 (m, 2 H, H-4,6), 7.07 (t, 1 H, J = 7.6 Hz, H-5), 6.80 (d, 1 H, J = 7.8 Hz, H-7), 3.75-3.60 (m, 1 H, H-3′), 3.18 (m, 3 H, NCH3), 2.70-2.10 (m, 2 H, H-1′), 1.80-1.35 (m, 4 H, H-2′, CH2CH3), 0.95-0.80 (m, 3 H, CH2CH3). 13C NMR (62.9 MHz, CDCl3): δ = 174.1 (CO), 143.0 (C-7a, 8da), 142.9 (C-7a, 8db), 130.7 (C-4), 129.7 (C-3a, 8da), 129.5 (C-3a, 8db), 124.6 (C-6), 124.0 (C-5, 8db), 123.9 (C-5, 8da), 109.1 (C-7), 65.1 (C-3′, 8db), 64.9 (C-3′, 8da), 64.7 (C-3), 36.8 (C-1′, 8db), 36.3 (C-1′, 8da), 33.1 (C-2′, 8db), 32.7 (C-2′, 8da), 31.8 (CH2, 8da), 31.5 (CH2, 8db), 27.1 (NCH3), 11.3 (CH2CH3). Anal. Calcd for C14H17Cl2NO: C, 58.75; H, 5.99; N, 4.89. Found: C, 58.80; H, 5.91; N, 4.99.
Compound 8g (major diastereomer, 8ga; minor diastereomer, 8gb): IR (film on NaCl): 3296.0 (NH), 1718.7 (C=O) cm-1. 1H NMR (250 MHz, CDCl3): δ = 8.96 (s, 1 H, NH, 8ga), 8.90 (s, 1 H, NH, 8gb), 6.96 (d, 1 H, J = 2.4 Hz, H-4), 6.88 (d, 1 H, J = 8.5 Hz, H-6), 6.82 (dd, 1 H, J = 8.5, 2.4 Hz, H-7), 4.05-3.85 (m, 1 H, H-3′), 3.81 (s, 3 H, OCH3), 2.60-2.40 (m, 2 H, H-1′), 2.40-2.20 (m, 2 H, H-2′), 1.48 (d, 3 H, J = 6.5 Hz, CH3, 8ga), 1.46 (d, 3 H, J = 6.3 Hz, CH3, 8gb). 13C NMR (62.9 MHz, CDCl3): δ = 177.1 (CO), 156.3 (C-5), 141.1 (C-7a), 134.1 (C-3a, 8gb), 133.8 (C-3a, 8ga), 115.7 (C-7, 8gb), 115.5 (C-7, 8ga), 111.8 (C-4, 8ga), 111.5 (C-4, 8gb), 111.3 (C-6), 68.0 (C-3), 58.2 (C-3′, 8gb), 58.0 (C-3′, 8ga), 56.2 (OCH3), 36.9 (C-1′, 8gb), 36.5 (C-1′, 8ga), 35.1 (C-2′, 8gb), 34.8 (C-2′, 8ga), 25.7 (CH3, 8gb), 25.5 (CH3, 8ga). Anal. Calcd for C13H15Cl2NO2: C, 54.18; H, 5.25; N, 4.86. Found: C, 53.95; H, 5.12; N, 4.75.
Data for 3-Chloro-1-methyl-3-(3-oxobutyl)oxindole
IR (film on NaCl): 1728.2, 1717.0 (C=O) cm-1. 1H NMR (250 MHz, CDCl3): δ = 7.39 (d, 1 H, J = 7.6 Hz, H-4), 7.37 (t, 1 H, J = 7.6 Hz, H-6), 7.15 (t, 1 H, J = 7.6 Hz, H-5), 6.87 (d, 1 H, J = 7.6 Hz, H-7), 3.25 (s, 3 H, NCH3), 2.65-2.40 (m, 4 H, H-1′,2′), 2.11 (s, 3 H, COCH3). 13C NMR (62.9 MHz, CDCl3): δ = 206.9 (C-3′), 173.9 (C-2), 142.7 (C-7a), 130.8 (C-4), 129.8 (C-3a), 124.5 (C-6), 123.9 (C-5), 109.2 (C-7), 64.4 (C-3), 38.4 (C-2′), 33.2 (C-1′), 30.4 (COCH3), 27.0 (NCH3). MS: m/z = 251 [M+]. Anal. Calcd for C13H14ClNO2: C, 62.03; H, 5.61; N, 5.56. Found: C, 62.35; H, 5.81; N, 5.62.
Indeed, compounds 8 were not obtained when oxalyl chloride was replaced by TFAA.